IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v489y2012i7414d10.1038_nature11303.html
   My bibliography  Save this article

Heterodimeric JAK–STAT activation as a mechanism of persistence to JAK2 inhibitor therapy

Author

Listed:
  • Priya Koppikar

    (Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center)

  • Neha Bhagwat

    (Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center
    Gerstner Sloan- Kettering Graduate School in Biomedical Sciences, Memorial Sloan-Kettering Cancer Center)

  • Outi Kilpivaara

    (Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center)

  • Taghi Manshouri

    (M. D. Anderson Cancer Center)

  • Mazhar Adli

    (Howard Hughes Medical Institute, Massachusetts General Hospital and Broad Institute of Harvard, Massachusetts Institute of Technology)

  • Todd Hricik

    (Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center)

  • Fan Liu

    (Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center)

  • Lindsay M. Saunders

    (Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center
    Gerstner Sloan- Kettering Graduate School in Biomedical Sciences, Memorial Sloan-Kettering Cancer Center)

  • Ann Mullally

    (Brigham and Women’s Hospital, Harvard Medical School)

  • Omar Abdel-Wahab

    (Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center
    Leukemia Service, Memorial Sloan-Kettering Cancer Center)

  • Laura Leung

    (Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center)

  • Abby Weinstein

    (Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center)

  • Sachie Marubayashi

    (Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center)

  • Aviva Goel

    (Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center)

  • Mithat Gönen

    (Memorial Sloan-Kettering Cancer Center)

  • Zeev Estrov

    (M. D. Anderson Cancer Center)

  • Benjamin L. Ebert

    (Brigham and Women’s Hospital, Harvard Medical School)

  • Gabriela Chiosis

    (Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center)

  • Stephen D. Nimer

    (Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center
    Leukemia Service, Memorial Sloan-Kettering Cancer Center)

  • Bradley E. Bernstein

    (Howard Hughes Medical Institute, Massachusetts General Hospital and Broad Institute of Harvard, Massachusetts Institute of Technology)

  • Srdan Verstovsek

    (M. D. Anderson Cancer Center)

  • Ross L. Levine

    (Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center
    Leukemia Service, Memorial Sloan-Kettering Cancer Center)

Abstract

Chronic exposure to JAK2 inhibitors leads to reactivation of downstream signalling through the formation of heterodimers between JAK2 and other JAK kinases in myeloproliferative neoplasms, which can be overcome with Hsp90 inhibitors.

Suggested Citation

  • Priya Koppikar & Neha Bhagwat & Outi Kilpivaara & Taghi Manshouri & Mazhar Adli & Todd Hricik & Fan Liu & Lindsay M. Saunders & Ann Mullally & Omar Abdel-Wahab & Laura Leung & Abby Weinstein & Sachie , 2012. "Heterodimeric JAK–STAT activation as a mechanism of persistence to JAK2 inhibitor therapy," Nature, Nature, vol. 489(7414), pages 155-159, September.
    • Handle: RePEc:nat:nature:v:489:y:2012:i:7414:d:10.1038_nature11303
    DOI: 10.1038/nature11303
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature11303
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/nature11303?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Zijian Fang & Giuditta Corbizi Fattori & Thomas McKerrell & Rebecca H. Boucher & Aimee Jackson & Rachel S. Fletcher & Dorian Forte & Jose-Ezequiel Martin & Sonia Fox & James Roberts & Rachel Glover & , 2023. "Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis," Nature Communications, Nature, vol. 14(1), pages 1-21, December.
    2. Hidehiro Itonaga & Adnan K. Mookhtiar & Sarah M. Greenblatt & Fan Liu & Concepcion Martinez & Daniel Bilbao & Masai Rains & Pierre-Jacques Hamard & Jun Sun & Afoma C. Umeano & Stephanie Duffort & Chua, 2024. "Tyrosine phosphorylation of CARM1 promotes its enzymatic activity and alters its target specificity," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
    3. Hongxing Shen & Fengyuan Huang & Xiangmin Zhang & Oluwagbemiga A. Ojo & Yuebin Li & Hoa Quang Trummell & Joshua C. Anderson & John Fiveash & Markus Bredel & Eddy S. Yang & Christopher D. Willey & Zech, 2022. "Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signaling," Nature Communications, Nature, vol. 13(1), pages 1-17, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:489:y:2012:i:7414:d:10.1038_nature11303. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.